Hims & Hers Health, Inc. (NYSE: HIMS) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $4.0B. The Maz Rating grades it against the other companies in its sector.
Hims & Hers Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $17.55, Hims & Hers Health, Inc. trades at 1.4x sales and 11.7x book value. Over the last twelve months it generated about $2.8B of revenue and a net loss of $184M. It runs a gross margin of 60.5%, an operating margin of -5.9% and a net margin of -6.7%. It shows return on equity of -45.8%, return on invested capital of -6.9% and a free cash flow yield of 0.8%. On the balance sheet: a debt-to-equity ratio of 4.39 and a current ratio of 0.92. Over the past 52 weeks the share price ranged from $13.74 to $40.99, with a beta of 2.50.
Hims & Hers Health, Inc. does not currently pay a dividend.
20 Wall Street analyst ratings cover the stock: 7 Buy and 13 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Hims & Hers Health, Inc. (HIMS) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 21.2% / 30% · (Cash+Inv) / Mkt Cap (36m) 11.0% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 21.2% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 11.0% / 33% · Receivables / Mkt Cap (36m) 6.63% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 21.2% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 11.0% / 33.33% · Receivables / Mkt Cap (24m) 6.63% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 40.4% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 24.8% / 33.33% · Receivables / Avg Assets (4Q) 8.49% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 38.6% / 33.33% · (Cash+ST Inv) / Total Assets 20.1% / 33.33% · (Cash+Recv) / Total Assets 32.1% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Hims & Hers Health, Inc. (HIMS) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Hims & Hers Health, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Hims & Hers Health, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.